Yubo International Biotech Ltd Quarterly Operating Margin in % from Q4 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Yubo International Biotech Ltd quarterly/annual Operating Margin history and growth rate from Q4 2022 to Q3 2024.
  • Yubo International Biotech Ltd Operating Margin for the quarter ending September 30, 2024 was -8.93K %, a 10063% decline year-over-year.
  • Yubo International Biotech Ltd annual Operating Margin for 2023 was -198 %, a 82.9% increase from 2022.
  • Yubo International Biotech Ltd annual Operating Margin for 2022 was -1.16K %, a 832% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -8.93K -8.84K -10063% Jul 1, 2024 Sep 30, 2024
Q2 2024 -309 +33.3 +9.74% Apr 1, 2024 Jun 30, 2024
Q1 2024 -285 +98.6 +25.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 -198 +958 +82.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 -87.9 Jul 1, 2023 Sep 30, 2023
Q2 2023 -342 Apr 1, 2023 Jun 30, 2023
Q1 2023 -384 Jan 1, 2023 Mar 31, 2023
Q4 2022 -1.16K Oct 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.